Augmedix, Inc. (AUGX)
Pre-market:
| Previous close | 1.2100 |
| Open | 1.1700 |
| Bid | 1.1400 x 600 |
| Ask | 1.1700 x 800 |
| Day's range | 1.1300 - 1.1750 |
| 52-week range | 0.9860 - 6.2500 |
| Volume | |
| Avg. volume | 656,898 |
| Market cap | 56.803M |
| Beta (5Y monthly) | 0.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. “Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins,” commented Manny Krakaris, Augmedix CEO. “We are confident about our positioning within the medical documentation market, and expect to report continued g
- GlobeNewswire
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024. RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1x1 investor meetings. The webcast link for the fireside chat can be found a
- GlobeNewswire
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=166669
